3′-azido-3′-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT
- 16 July 1999
- journal article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 428 (1-2) , 41-47
- https://doi.org/10.1016/s1383-5742(99)00030-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacologyInternational Journal of Obstetric Anesthesia, 2000
- Prevention of vertical HIV transmissionAIDS, 1998
- Effect of Zidovudine Treatment in Late Pregnancy on HIV-1 In Utero TransmissionAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1997
- Pharmacokinetic and Toxicity Studies of AZT (Zidovudine) Following Perfusion of Human Term Placenta for 14 HoursToxicology and Applied Pharmacology, 1997
- Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country settingPublished by American Medical Association (AMA) ,1996
- Transfer of Lidocaine and Bupivacaine Across the Isolated Perfused Human Placenta *Basic & Clinical Pharmacology & Toxicology, 1995
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placentaAmerican Journal of Obstetrics and Gynecology, 1992
- Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patientsAntiviral Research, 1991
- Azidothymidine (Zidovudine) Transport by the Human PlacentaThe Lancet Healthy Longevity, 1990